Skip to main content

Hemangeol FDA Approval History

FDA Approved: Yes (First approved March 14, 2014)
Brand name: Hemangeol
Generic name: propranolol hydrochloride
Dosage form: Oral Solution
Company: Pierre Fabre Dermatologie
Treatment for: Infantile Hemangioma

Hemangeol (propranolol hydrochloride) is a pediatric beta-blocker formulation indicated for the treatment of proliferating infantile hemangioma.

Development timeline for Hemangeol

Mar 18, 2014Approval Pierre Fabre Obtains FDA Approval to Market Hemangeol for the Treatment of Infantile Hemangioma

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.